Navigation Links
Oncolytics Biotech Inc. Announces 2008 Second Quarter Results
Date:7/29/2008

CALGARY, July 29 /PRNewswire-FirstCall/ - Oncolytics Biotech Inc. ("Oncolytics") (TSX:ONC, NASDAQ:ONCY) today announced its financial results and highlights for the three and six month periods ended June 30, 2008.

"Oncolytics experienced a strong second quarter with the reporting of durable clinical responses to REOLYSIN(R) combination therapy treatment in refractory head and neck cancer patients," said Dr. Brad Thompson, President and CEO of Oncolytics. "We are enrolling increasing numbers of patients in our clinical program for REOLYSIN(R), and the positive results from these trials are helping us to plan the later-stage development program for REOLYSIN(R)."

Second Quarter Highlights

Significant Clinical Advances

- Presented positive interim U.S. Phase II sarcoma trial results at the

American Society of Clinical Oncology (ASCO) annual meeting, showing 8

of 16 evaluable patients experienced stable disease for periods

ranging from two to more than ten, 28-day cycles.

- Presented positive interim results from a U.K. combination REOLYSIN(R)

and paclitaxel/carboplatin trial at the British Society of Gene

Therapy (BSGT) conference in Edinburgh. Three head and neck patients

evaluated at that time had excellent clinical and radiological

responses without appreciable toxicity. The dose escalation portion of

this trial was completed in the second quarter.

- Received approval for U.K. and U.S. Phase II clinical trials

investigating REOLYSIN(R) in combination with paclitaxel and

carboplatin, and started patient enrolment in the U.K. trial.

- The U.S. National Cancer Institute started patient enrolment in a

Phase I/II ovarian, peritoneal and fallopian tube cancer trial using

systemic and intraperitoneal administration of REOLYSIN(R).

- Started patient enrolment in a U.K. combination REOLYSIN(R) and'/>"/>

SOURCE Oncolytics Biotech Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33

Related biology technology :

1. Oncolytics Biotech Inc. Announces Issuance of 23rd U.S. Patent
2. Oncolytics Biotech Inc. Reports Positive Interim Results of U.K. Phase Ia/Ib Combination REOLYSIN(R) and Radiation Clinical Trial
3. Media Advisory - Oncolytics Biotech Inc. to Present at BioPartnering Europe
4. Media Advisory - Oncolytics Biotech Inc. to Present at BIO InvestorForum 2007
5. Oncolytics Biotech Inc. Announces Approval for U.K. Clinical Trial Investigating REOLYSIN(R) in Combination with Cyclophosphamide
6. Oncolytics Biotech Inc. Collaborators to Present Positive Interim Results of U.K. Phase Ia/Ib Combination REOLYSIN(R) and Radiation Clinical Trial
7. Oncolytics Biotech Inc. Announces 2007 Third Quarter Results
8. Media Advisory - Oncolytics Biotech Inc. to Present at Acumen BioFin Rodman & Renshaw 9th Annual Healthcare Conference
9. Media Advisory - Oncolytics Biotech Inc. to Present at Toronto CFA Society
10. Oncolytics Biotech Inc. Announces Issuance of 24th U.S. Patent
11. Oncolytics Biotech Inc. to Present at Annual Vaccine Production Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/18/2013)... In support of Swiss contributions to ... of Switzerland in New York is pleased to welcome ... PlanetSolar , to Manhattan. PlanetSolar is in New ... tour with scientists on board from the University of ... exclusively on energy from the sun and eliminates the ...
(Date:6/18/2013)... The human skin is the largest organ, yet many do ... Similar to the liver, or heart, the skin must be ... Recent reports from the mankatofreepress.com explained how caring for the ... other life supporting organs. The article suggests several types of ... the appearance of skin, and fight off acne causing factors. ...
(Date:6/18/2013)... The Pistoia Alliance is ... biomolecular representation standard software toolkit and editor under ... HELM (Hierarchical Editing Language for Macromolecules) enables the ... proteins, nucleotides, antibody drug conjugates) whose size and ... impractical or unusable. HELM solves this problem through ...
(Date:6/18/2013)... , June 18, 2013 The ... (Sequencing Platforms, Knowledge Management Tools & Data Analysis Services) & ... and studies the Major Market Drivers, Restraints, and Opportunities in ... , Asia-Pacific and Rest of World. ... Tables 22 Figures ...
Breaking Biology Technology:Switzerland’s MS Tûranor PlanetSolar, the World’s Largest Solar Boat, Arrives in New York City 2Switzerland’s MS Tûranor PlanetSolar, the World’s Largest Solar Boat, Arrives in New York City 3Switzerland’s MS Tûranor PlanetSolar, the World’s Largest Solar Boat, Arrives in New York City 4Natural Acne Remedies Through Diet, Probiotic Action Shares New Insight on What Foods May Help Lead to Clear Skin 2The Pistoia Alliance Releases HELM Biomolecular Representation Standard Open Source Tools 2Bioinformatics Market Worth $7.5 Billion by 2017 2Bioinformatics Market Worth $7.5 Billion by 2017 3
... Therapy May Control Staph Infections in Humans Including ... a bacteriophage active against Staphylococcus aureus, including methicillin-resistant ... report their findings in the August 2007 issue ... S. aureus is a highly flexible and potentially ...
... news for public health: Bioengineering researchers from the EPFL ... that can deliver vaccines more effectively, with fewer side ... current vaccine technologies. , Described in an article ... the vaccine delivery platform is a deceptively simple combination ...
... Engineers at Rensselaer Polytechnic Institute have developed tools to help ... stem cell research how to quickly test stem cell ... a large supply of healthy, viable stem cells to study ... created methods to study millions of stems cells on devices ...
Cached Biology Technology:Tips from the Journals of the American Society for Microbiology 2Tips from the Journals of the American Society for Microbiology 3New nanoparticle vaccine is more effective but less expensive 2New nanoparticle vaccine is more effective but less expensive 3Putting stem cell research on the fast track 2Putting stem cell research on the fast track 3Putting stem cell research on the fast track 4
(Date:6/17/2013)... CA June 17, 2013 An international team ... the Howard Hughes Medical Institute and Albert Einstein College ... promising new anti-tuberculosis compound that attacks the tuberculosis (TB) ... an effort to help solve one of the major ... and its dangerous drug-resistant strains," said Peter G. Schultz, ...
(Date:6/17/2013)... -- In research published in Biochemical and Biophysical ... technology that can detect new, previously unknown viruses. The ... even when doctors have not identified a particular virus ... , In the new approach, scientists use blood serum ... , Taking advantage of the complete deciphering of the ...
(Date:6/17/2013)... SAN FRANCISCO-- Vitamin D supplementation may help delay early ... finds. The results were presented Monday at The Endocrine ... girls, puberty generally begins between the ages of 10 ... 12 to 16 years of age. Precocious puberty is ... age of 8; in boys, it is diagnosed when ...
Breaking Biology News(10 mins):New compound excels at killing persistent and drug-resistant tuberculosis 2New compound excels at killing persistent and drug-resistant tuberculosis 3New compound excels at killing persistent and drug-resistant tuberculosis 4Saint Louis University researchers discover a way to detect new viruses 2Saint Louis University researchers discover a way to detect new viruses 3Vitamin D supplementation may delay precocious puberty in girls 2
... JUPITER, FL -- Inspired by natural products, scientists on ... created a new class of small molecules with the ... discovery. Combining the power of synthetic chemistry with ... expand by millions the number of provocative synthetic compounds ...
... fishes in many Great Plains streams has been significantly reduced ... and scientists analyzing the water loss say ecological futures ... have been published in the journal Ecohydrology . ... and snow, these regional aquifers were filled by melting glaciers ...
... do people with a hereditary mutation of the red ... anemia prevalent in Africa) not contract severe malaria? Scientists ... the Department of Infectious Diseases at Heidelberg University Hospital ... the altered hemoglobin provides protection from severe malaria. Within ...
Cached Biology News:Scripps research scientists develop brand new class of small molecules through innovative chemistry 2Scripps research scientists develop brand new class of small molecules through innovative chemistry 3Great Plains river basins threatened by pumping of aquifers 2Great Plains river basins threatened by pumping of aquifers 3Protection from severe malaria explained 2Protection from severe malaria explained 3
... nucleic acids ,The GC-RICH PCR System, ... a proofreading polymerase, powers through templates that ... other polymerases and other blends of polymerases. ... the unique GC-RICH Resolution Solution combine to ...
... synthetic peptide corresponding to the third cytoplasmic ... receptor, conjugated to KLH. The immunizing peptide ... mouse gene. Physical form: Solution in ... sodium azide. Titertest method: IHC (p). ...
Canine Chondrocytes (CnC) (500,000 cells)...
... Fluorescein 6-Fam, Hex, Tet Cy3, ... Fluorescein Tamra Black Hole Quenchers Molecular ... Tet Tamra, Joe 3 Dabcyl ... New York Double labelled probes are purified ...
Biology Products: